Kifude Carolyne M, Rajasekariah Halli G, Sullivan David J, Stewart V Ann, Angov Evelina, Martin Samuel K, Diggs Carter L, Waitumbi John N
Walter Reed Project/Kenya Medical Research Institute, Kisumu, Kenya.
Clin Vaccine Immunol. 2008 Jun;15(6):1012-8. doi: 10.1128/CVI.00385-07. Epub 2008 Mar 26.
Microscopy, the gold standard for the detection and quantification of malaria parasites in blood, is in many aspects deficient for this purpose. The method is poorly reproducible and can be inaccurate because Plasmodium falciparum parasites sequester for a portion of each asexual cycle. Due to these deficiencies, biomarkers such as P. falciparum histidine-rich protein 2 (PfHRP2) are increasingly being used. In this study, we evaluated the use of a commercial PfHRP2 enzyme-linked immunosorbent assay (ELISA) kit with some procedural modifications. We determined the linear range of the assay, including the lower limits of detection and quantitation, using recombinant PfHRP2 (rPfHRP2). In 10 repeat experiments, the linear range of optical densities (ODs) at 450 to 650 nm was from 0.05 +/- 0.002 to 2.28 +/- 0.042, corresponding to 3.91 to 250 ng/ml of rPfHRP2. The coefficient of variation (CV) at each target concentration ranged from 1.93 to 8.07%. Using cultured parasites, we confirmed the linear range of ODs as well as the association between the PfHRP2 ELISA results and the microscopic parasite densities. For whole-blood samples spiked with cultured, washed, ring-stage-infected red blood cells (iRBCs), the linear range was 11.7 to 750 iRBCs/microl, with CVs of 0.29 to 7.56%. The same spiked samples evaluated by microscopists had similar sensitivities, but the CVs were unacceptably high (20.7 to 161.6%). Stock rPfHRP2 was stable through four freeze-thaw cycles (P < 0.05; paired t test). When different patient sample types at different concentrations within the linear range of the assay are compared, the recoveries of PfHRP2 from blood and serum were within +/-20%, whereas the recoveries from plasma ranged between +35 and -41%. We conclude that PfHRP2 ELISA using whole-blood and serum samples is a suitable adjunct to microscopy and could ultimately benefit malaria intervention trials.
显微镜检查是检测和定量血液中疟原虫的金标准,但在很多方面存在不足。该方法重复性差且可能不准确,因为恶性疟原虫在每个无性繁殖周期的一部分时间里会隐匿起来。由于这些缺陷,诸如恶性疟原虫富含组氨酸蛋白2(PfHRP2)等生物标志物正越来越多地被使用。在本研究中,我们对一种商用PfHRP2酶联免疫吸附测定(ELISA)试剂盒进行了一些程序上的改进并评估了其用途。我们使用重组PfHRP2(rPfHRP2)确定了该测定的线性范围,包括检测下限和定量下限。在10次重复实验中,450至650 nm处光密度(OD)的线性范围为0.05±0.002至2.28±0.042,对应于3.91至250 ng/ml的rPfHRP2。每个目标浓度下的变异系数(CV)在1.93%至8.07%之间。使用培养的疟原虫,我们确认了OD的线性范围以及PfHRP2 ELISA结果与显微镜下疟原虫密度之间的关联。对于添加了培养、洗涤后的环状期感染红细胞(iRBC)的全血样本,线性范围为11.7至750个iRBC/微升,CV为0.29%至7.56%。显微镜检查人员评估的相同添加样本具有相似的灵敏度,但CV高得令人无法接受(20.7%至161.6%)。储备rPfHRP2在经过四个冻融循环后仍保持稳定(P<0.05;配对t检验)。当比较测定线性范围内不同浓度的不同患者样本类型时,血液和血清中PfHRP2的回收率在±20%以内,而血浆中的回收率在+35%至-41%之间。我们得出结论,使用全血和血清样本的PfHRP2 ELISA是显微镜检查的合适辅助手段,最终可能会使疟疾干预试验受益。